# DEFERASIROX
> **ANDA214559** · Abbreviated New Drug Application (Generic) · Sponsor: AUCTA · Approved 2021-03-09
## Drug
- **FDA Application Number:** ANDA214559
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** DEFERASIROX
- **Generic name:** DEFERASIROX
- **Active ingredients:** DEFERASIROX
- **Dosage form:** GRANULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** AUCTA
- **Manufacturer:** EPIC PHARMA, LLC
- **First approval:** 2021-03-09
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214559)
---
*MORVS · CC0 1.0*